Brief: Cipher Pharmaceuticals appoints Robert Tessarolo as CEO
20/03/2017 20:00
March 20 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher Pharmaceuticals appoints Robert Tessarolo as CEO
* Says Tessarolo has been appointed president and chief
executive officer of Cipher, effective April 17, 2017
* Cipher Pharmaceuticals Inc - Tessarolo most recently held
position of vice president & general manager with Celgene
Corporation
Source text for Eikon: ID:nCNW4zWVPa
Further company coverage: CPH.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million